40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.96%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-36.13%
Negative gross profit growth while OBE is at 81.36%. Joel Greenblatt would examine cost competitiveness or demand decline.
-206.50%
Negative EBIT growth while OBE is at 93.89%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-206.50%
Negative operating income growth while OBE is at 83.11%. Joel Greenblatt would press for urgent turnaround measures.
38.07%
Net income growth under 50% of OBE's 93.77%. Michael Burry would suspect the firm is falling well behind a key competitor.
38.02%
EPS growth under 50% of OBE's 93.75%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
38.57%
Diluted EPS growth under 50% of OBE's 93.79%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.10%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.81%
Diluted share change of 0.81% while OBE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-66.63%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-64.96%
Negative OCF growth while OBE is at 125.93%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-220.24%
Negative FCF growth while OBE is at 159.72%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-81.09%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-60.51%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-38.33%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-91.99%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-78.32%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-59.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-130.15%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-524.79%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
23.73%
3Y net income/share CAGR above 1.5x OBE's 1.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-61.08%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-71.55%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
1.55%
Positive short-term equity growth while OBE is negative. John Neff sees a strong advantage in near-term net worth buildup.
-76.18%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.27%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-92.33%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-36.84%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while OBE stands at 111.11%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.82%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-10.64%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
1.00%
We have some new debt while OBE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-0.85%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.